EirGenix Inc. (TWSE: 6589)
Health Care · Life Sciences Tools & Services · TW
NT$51.20
-0.58% today · -16.7% 1Y
EirGenix Inc. (TWSE: 6589) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $487.00M and employs 1,000 people.
Over the last twelve months the share price has lost 16.7%, trading between 40.15 and 84.30.
Tweenvest scores EirGenix Inc. across four factors: quality 52/100, value 64/100. Its strongest factor is value.
6589 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $487.00M
- Revenue (TTM)
- $38.14M
- P/E
- —
- EPS
- -1.89
- Dividend yield
- —
- Beta (5Y)
- 0.31
- 52-week high
- NT$84.30
- 52-week low
- NT$40.15
- Avg volume (3M)
- —
- Shares outstanding
- 302.88M
- Employees
- 1,000
- Next earnings
- —
About EirGenix Inc.
EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatment of cancer and currently under biologics license application status; EG1206A, a Pertuzumab biosimilar, indicated for the treatment of cancer and currently under Phase I stage; EG13074, indicated for the treatment of cancer and currently under Preclinical stage; TSY0110(EG12043), an antibody-drug conjugate, indicated for the treatment of cancer and currently under Preclinical stage; EG12021, Bevacizumab biosimilar, indicated for the treatment of cancer and currently under Preclinical stage; and EG62054, a biosimilar, currently under Preclinical stage. In addition, the company manufactures and sells covid-19 antigen rapid test; and EG74032, a CRM197 carrier protein. The company was incorporated in 2012 and is headquartered in New Taipei City, Taiwan.
- ISIN
- TW0006589005
- Founded
- 2012
- Listed since
- Nov 23, 2016
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $633.71 | +0.89% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.36 | -0.28% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $155.08 | +0.20% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.51 | +0.81% |
| Waters CorporationNYSE: WAT | $40.72B | $414.17 | -0.07% |
Figures last refreshed Aug 18, 2026.